EF
AZN icon

Empowered Funds’s AstraZeneca AZN Stock Holding History

Empowered Funds’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Sell
5,513
-13,917
-72% -$2.62M 0.01% 1446
2026
Q1 		$3.83M Buy
+19,430
New +$3.75M 0.02% 756
2025
Q4 		– Sell
-14,100
Closed -$2.16M – 1074
2025
Q3 		$2.16M Buy
+14,100
New +$2.13M 0.02% 887

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Empowered Funds's AZN Position: Q2 2026 in Review

Empowered Funds reduced its AstraZeneca (AZN) stake by 72% in Q2 2026, selling an estimated $2.62M and leaving 5,513 shares worth $1.05M. The position accounts for 0.01% of the portfolio, ranked #1446.

Empowered Funds first reported a position in AZN in Q3 2025 and has held it in 3 quarters since. The position peaked at $3.83M in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Empowered Funds held 5,513 shares of AstraZeneca worth $1.05M as of Q2 2026.
  • Empowered Funds sold 13,917 AstraZeneca shares in Q2 2026, an estimated $2.62M.
  • AstraZeneca made up 0.01% of Empowered Funds's portfolio in Q2 2026, its #1446 holding.
  • Empowered Funds first reported a position in AstraZeneca in Q3 2025 and has held it in 3 quarters since.
  • Empowered Funds's AstraZeneca position peaked at $3.83M in Q1 2026.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.